Lorenskog, Norway

Tormod Fladby

This inventor holds 4 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Inven2 as. Active years: 2017-2024.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Lorenskog, NO (2017 - 2019)
  • Blommenholm, NO (2022 - 2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tormod Fladby: Innovator in Phagocytic Activity Monitoring

Introduction

Tormod Fladby is a notable inventor based in Lorenskog, Norway. He has made significant contributions to the field of medical diagnostics, particularly in monitoring phagocytic activity. With a total of 4 patents to his name, Fladby has focused on developing methods and compositions that aid in the diagnosis and assessment of neurodegenerative diseases.

Latest Patents

Fladby's latest patents include innovative methods and compositions for monitoring phagocytic activity. These inventions are particularly relevant for diagnosing and assessing the risk of neurodegenerative diseases, such as Alzheimer's disease (AD). His work emphasizes the importance of understanding phagocytic activity in relation to various diseases and conditions.

Career Highlights

Throughout his career, Tormod Fladby has worked with prominent organizations, including Inven2 and Akershus Universitetssykehus. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in medical diagnostics.

Collaborations

Fladby has collaborated with notable colleagues, including Lisbeth Johnsen and Hanne Mali Mollergard. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Tormod Fladby is a distinguished inventor whose work in monitoring phagocytic activity has the potential to impact the diagnosis of neurodegenerative diseases significantly. His contributions to the field are invaluable, and his ongoing research continues to pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…